A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin ...
Teplizumab, also known as Tzield and made by Sanofi, is approved for children aged 8 and over and adults who have early-stage ...
Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...
The immunotherpay can give children and adults three extra years before they need to use insulin.
Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’ ...
Add Yahoo as a preferred source to see more of our stories on Google. Hundreds of people reported experiencing severe pancreas problems after taking these drugs, according to the BBC. The UK ...
In a landmark announcement, the NHS has introduced a beacon of hope for individuals susceptible to type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results